Evidence map›Paper›PMID 24076051›Full record

ArticleImmunity2013

CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity.

Yosuke Kumamoto, Melissa Linehan, Jason S Weinstein, Brian J Laidlaw, Joseph E Craft, Akiko Iwasaki

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 239 papers.

0numbers the graph read from it
0cells of the map it votes in
239citing papers in PubMed
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

239 citing papers in PubMed, 391 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Thymic Dendritic Cells Revisited.Immunological reviews · 2025
    Review

179 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yosuke KumamotoDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Melissa Linehan
Jason S Weinstein
Brian J Laidlaw
Joseph E Craft
Akiko Iwasaki
Yale University · US

Funding

TRAINING PROGRAM IN INVESTIGATIVE RHEUMATOLOGYT32AR007107 · NIAMS · YALE UNIVERSITY · PI RICHARD J BUCALA · 1986 to 2026
$7.5M
IMMUNE RESPONSES IN LUPUSR37AR040072 · NIAMS · YALE UNIVERSITY · PI CRAFT, JOSEPH EDGAR · 2000 to 2025
$7.4M
Yale Rheumatic Diseases Research Core CenterP30AR053495 · NIAMS · YALE UNIVERSITY · PI SHLOMCHIK, WARREN D · 2007 to 2017
$7.0M
Immunity to Genital Herpes Simplex-2R01AI054359 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2004 to 2019
$5.2M
GENETIC ANALYSIS OF T CELLS IN LUPUSR01AR044076 · NIAMS · YALE UNIVERSITY · PI CRAFT, JOSEPH EDGAR · 1996 to 2010
$4.1M
Antiviral CTL mobilization to the genital mucosaR01AI062428 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2005 to 2015
$3.9M
MOLECULAR CHARACTERIZATION OF THE SNRNP POLYPEPTIDESR01AR040072 · NIAMS · YALE UNIVERSITY · PI Joseph Edgar Craft · 1990 to 2026
$2.5M
Antiviral CTL mobilization to the genital mucosaR56AI062428 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2010 to 2010
$403k
NIAID NIH HHS AI054359NIAID NIH HHS AI062428NIAID NIH HHS R01 AI054359NIAID NIH HHS R01 AI062428NIAID NIH HHS R56 AI062428NIAMS NIH HHS AR40072NIAMS NIH HHS AR44076NIAMS NIH HHS P30 AR053495NIAMS NIH HHS R01 AR040072NIAMS NIH HHS R01 AR044076NIAMS NIH HHS R37 AR040072NIAMS NIH HHS T32 AR007107
6 · The paper itself

Abstract

Unlike other types of T helper (Th) responses, whether the development of Th2 cells requires instruction from particular subset of dendritic cells (DCs) remains unclear. By using an in vivo depletion approach, we have shown that DCs expressing CD301b were required for the generation of Th2 cells after subcutaneous immunization with ovalbumin (OVA) along with papain or alum. CD301b⁺ DCs are distinct from epidermal or CD207⁺ dermal DCs (DDCs) and were responsible for transporting antigen injected subcutaneously with Th2-type adjuvants. Transient depletion of CD301b⁺ DCs resulted in less effective accumulation and decreased expression of CD69 by polyclonal CD4⁺ T cells in the lymph node. Moreover, despite intact cell division and interferon-γ production, CD301b⁺ DC depletion led to blunted interleukin-4 production by OVA-specific OT-II transgenic CD4⁺ T cells and significantly impaired Th2 cell development upon infection with Nippostrongylus brasiliensis. These results reveal CD301b⁺ DDCs as the key mediators of Th2 immunity.

Indexed as

Immunity, CellularAllergensAlum CompoundsAnimalsCell DifferentiationDendritic CellsGene Expression RegulationInterleukin-4Lectins, C-TypeMiceMice, TransgenicNippostrongylusOvalbuminSignal TransductionSkinStrongylida InfectionsAllergensAlum Compoundsaluminum sulfateInterleukin-4Lectins, C-TypeMGL2 protein, mouseOvalbumin

Identifiers

PMID24076051
PMCPMC3819035
OpenAlexW2066177626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.